MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway

(2016) Shubin Hong et al.   THYROID

Secreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activation

(2015) Yanhua Zheng et al.   NATURE CELL BIOLOGY

The miR-15 Family Enhances the Radiosensitivity of Breast Cancer Cells by Targeting G2Checkpoints

(2015) Zijie Mei et al.   RADIATION RESEARCH

Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas

(2015) Hui Sun et al.   OncoTargets and Therapy

miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells

(2015) Chunhui Liu et al.   PLoS One

miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2)

(2014) Xiao-hui Sun et al.   TUMOR BIOLOGY

MicroRNA-222 and MicroRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer

(2013) James C. Lee et al.   CANCER

The Clinical and Economic Burden of a Sustained Increase in Thyroid Cancer Incidence

(2013) B. Aschebrook-Kilfoy et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth

(2013) Bisheng Zhou et al.   CANCER LETTERS

Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma

(2013) Jie Ding et al.   HEPATOLOGY

MicroRNA-195 Suppresses Angiogenesis and Metastasis of Hepatocellular Carcinoma by Inhibiting the Expression of VEGF, VAV2, and CDC42

(2013) Ruizhi Wang et al.   HEPATOLOGY

In-Depth Characterization of the MicroRNA Transcriptome in Normal Thyroid and Papillary Thyroid Carcinoma

(2013) Michal Swierniak et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

miR-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma, Where It Interferes with Cell-Cycle Regulation

(2012) J. Cai et al.   CANCER RESEARCH

MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene

(2012) Xia Liu et al.   CELL CYCLE

Circulating MicroRNA Profiles as Potential Biomarkers for Diagnosis of Papillary Thyroid Carcinoma

(2012) Shuang Yu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prognostic Implications of miR-146b Expression and Its Functional Role in Papillary Thyroid Carcinoma

(2012) Chen-Kai Chou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

FGF-2 Regulates Cell Proliferation, Migration, and Angiogenesis through an NDY1/KDM2B-miR-101-EZH2 Pathway

(2011) Filippos Kottakis et al.   MOLECULAR CELL

Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005

(2009) L. Enewold et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases

(2009) Bryan T. MacDonald et al.   DEVELOPMENTAL CELL

MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells

(2009) Teng Xu et al.   HEPATOLOGY

International patterns and trends in thyroid cancer incidence, 1973–2002

(2008) Briseis A. Kilfoy et al.   CANCER CAUSES & CONTROL

The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

(2008) Désirée Bonci et al.   NATURE MEDICINE